Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M White

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Environmental Science and Pollution Research International|June 18, 2021
A method and its application to determine the amount of cannabinoids in sewage sludge and biosolidsAaron J Pandopulos, Bradley S Simpson, Richard Bade, et al.
Drug Testing and Analysis|July 5, 2020
The complexities associated with new psychoactive substances in influent wastewater: The case of 4-ethylmethcathinoneRichard Bade, Vincenzo Abbate, Ahmed Abdelaziz, et al.
British Journal of Clinical Pharmacology|November 19, 2011
Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjectsEloise A Gelston, Janet K Coller, Olga V Lopatko, et al.
Plos One|February 19, 2013
Illicit stimulant use is associated with abnormal substantia nigra morphology in humansGabrielle Todd, Carolyn Noyes, Stanley C Flavel, et al.
Drug and Alcohol Dependence|August 22, 2021
Adults with a history of recreational cannabis use have altered speech productionAdam P Vogel, Verity Pearson-Dennett, Michelle Magee, et al.
British Journal of Clinical Pharmacology|February 29, 2012
Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patientsJanet K Coller, Jennifer R Michalakas, Heather M James, et al.
Pharmacogenomics and Personalized Medicine|December 11, 2012
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogeneticsDaniel T Barratt, Janet K Coller, Richard Hallinan, et al.
The Science of the Total Environment|October 6, 2018
LC-HRMS suspect screening to show spatial patterns of New Psychoactive Substances use in AustraliaRichard Bade, Benjamin J Tscharke, Jason M White, et al.
Talanta|June 6, 2020
Towards an efficient method for the extraction and analysis of cannabinoids in wastewaterAaron J Pandopulos, Richard Bade, Jake W O'Brien, et al.
Pharmacology, Biochemistry, and Behavior|September 13, 2015
Acute opioid administration induces hypothalamic-pituitary-adrenal activation and is mediated by genetic variation in interleukin (Il)1BStephanie G Kershaw, Chris B Della Vedova, Irina Majumder, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Environmental Science and Pollution Research International|June 18, 2021
A method and its application to determine the amount of cannabinoids in sewage sludge and biosolidsAaron J Pandopulos, Bradley S Simpson, Richard Bade, et al.
Drug Testing and Analysis|July 5, 2020
The complexities associated with new psychoactive substances in influent wastewater: The case of 4-ethylmethcathinoneRichard Bade, Vincenzo Abbate, Ahmed Abdelaziz, et al.
British Journal of Clinical Pharmacology|November 19, 2011
Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjectsEloise A Gelston, Janet K Coller, Olga V Lopatko, et al.
Plos One|February 19, 2013
Illicit stimulant use is associated with abnormal substantia nigra morphology in humansGabrielle Todd, Carolyn Noyes, Stanley C Flavel, et al.
Drug and Alcohol Dependence|August 22, 2021
Adults with a history of recreational cannabis use have altered speech productionAdam P Vogel, Verity Pearson-Dennett, Michelle Magee, et al.
British Journal of Clinical Pharmacology|February 29, 2012
Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patientsJanet K Coller, Jennifer R Michalakas, Heather M James, et al.
Pharmacogenomics and Personalized Medicine|December 11, 2012
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogeneticsDaniel T Barratt, Janet K Coller, Richard Hallinan, et al.
The Science of the Total Environment|October 6, 2018
LC-HRMS suspect screening to show spatial patterns of New Psychoactive Substances use in AustraliaRichard Bade, Benjamin J Tscharke, Jason M White, et al.
Talanta|June 6, 2020
Towards an efficient method for the extraction and analysis of cannabinoids in wastewaterAaron J Pandopulos, Richard Bade, Jake W O'Brien, et al.
Pharmacology, Biochemistry, and Behavior|September 13, 2015
Acute opioid administration induces hypothalamic-pituitary-adrenal activation and is mediated by genetic variation in interleukin (Il)1BStephanie G Kershaw, Chris B Della Vedova, Irina Majumder, et al.
Pageof 13